BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 38551491)

  • 1. Trimethylation Enhancement Using (13)C-Diazomethane ((13)C-TrEnDi): Increased Sensitivity and Selectivity of Phosphatidylethanolamine, Phosphatidylcholine, and Phosphatidylserine Lipids Derived from Complex Biological Samples.
    Canez CR; Shields SW; Bugno M; Wasslen KV; Weinert HP; Willmore WG; Manthorpe JM; Smith JC
    Anal Chem; 2016 Jul; 88(14):6996-7004. PubMed ID: 27275841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An In Silico Database for Automated Feature Identification of High-Resolution Tandem Mass Spectrometry
    Roberts JA; Rosales CA; Wasslen KV; Radnoff AS; Godbout E; Diallo JS; Manthorpe JM; Smith JC
    J Am Soc Mass Spectrom; 2023 Dec; 34(12):2722-2730. PubMed ID: 37929927
    [No Abstract]   [Full Text] [Related]  

  • 3. Trimethylation enhancement using diazomethane (TrEnDi) II: rapid in-solution concomitant quaternization of glycerophospholipid amino groups and methylation of phosphate groups via reaction with diazomethane significantly enhances sensitivity in mass spectrometry analyses via a fixed, permanent positive charge.
    Wasslen KV; Canez CR; Lee H; Manthorpe JM; Smith JC
    Anal Chem; 2014 Oct; 86(19):9523-32. PubMed ID: 25208053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethylation Enhancement Using
    Betancourt SK; Canez CR; Shields SWJ; Manthorpe JM; Smith JC; McLuckey SA
    Anal Chem; 2017 Sep; 89(17):9452-9458. PubMed ID: 28764333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethylation Enhancement Using Diazomethane (TrEnDi) Enables Enhanced Detection of Glufosinate and 3-(Methylphosphinico)propionic Acid from Complex Canola Samples.
    Rosales CA; Sheedy KL; Wasslen KV; Manthorpe JM; Smith JC
    J Am Soc Mass Spectrom; 2024 Jan; 35(1):140-150. PubMed ID: 38127770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized
    Shields SWJ; Canez CR; Rosales CA; Roberts JA; Bourgaize H; Pallister PJ; Manthorpe JM; Smith JC
    J Am Soc Mass Spectrom; 2024 May; 35(5):972-981. PubMed ID: 38551491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricky Isomers-The Evolution of Analytical Strategies to Characterize Plasmalogens and Plasmanyl Ether Lipids.
    Koch J; Watschinger K; Werner ER; Keller MA
    Front Cell Dev Biol; 2022; 10():864716. PubMed ID: 35573699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical methods for (oxidized) plasmalogens: Methodological aspects and applications.
    Fuchs B
    Free Radic Res; 2015 May; 49(5):599-617. PubMed ID: 25536419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal plasmalogen levels are maintained in tissues from mice with hepatocyte-specific deletion in peroxin 5.
    Werner ER; Swinkels D; Juric V; Dorninger F; Baes M; Keller MA; Berger J; Watschinger K
    Brain Res Bull; 2023 Feb; 193():158-165. PubMed ID: 36584717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrospray ionization with low-energy collisionally activated dissociation tandem mass spectrometry of glycerophospholipids: mechanisms of fragmentation and structural characterization.
    Hsu FF; Turk J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2673-95. PubMed ID: 19269264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis.
    Lessig J; Fuchs B
    Curr Med Chem; 2009; 16(16):2021-41. PubMed ID: 19519379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmalogen Replacement Therapy.
    Bozelli JC; Epand RM
    Membranes (Basel); 2021 Oct; 11(11):. PubMed ID: 34832067
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.